Multibagger Pharma Company Expands into New Territory with Innovative Pediatric Solution Multibagger Pharma Company Expands into New Territory with Innovative Pediatric Solution The stock has delivered 85 per cent in 1 year and gave multibagger returns of 240 per cent in 2 years. DSIJ Intelligence / Saturday, March 22, 2025 0 143 Article rating: 5.0 The stock has delivered 85 per cent in 1 year and gave multibagger returns of 240 per cent in 2 years. Read more
Pharma Giant Expands with Strategic Acquisition in Singapore Pharma Giant Expands with Strategic Acquisition in Singapore The company has a strong presence in regulated markets such as the United States and Europe and is a leading producer of niche generic formulations. DSIJ Intelligence / Thursday, March 20, 2025 0 165 Article rating: 4.0 The company has been actively expanding its product pipeline, with over 70 commercialized products and a healthy pipeline of 100+ approved products. Read more
42.4% Returns From 52-Week Low: Pharma Stock Under Rs 75 Jumps 19.9%; Do You Own It? 42.4% Returns From 52-Week Low: Pharma Stock Under Rs 75 Jumps 19.9%; Do You Own It? The company has a market cap of over Rs 380 crore and the stock is up by 42.4 per cent from its 52-week low of Rs 50.42 per share. DSIJ Intelligence / Friday, March 7, 2025 0 203 Article rating: 5.0 The company has a market cap of over Rs 380 crore and the stock is up by 42.4 per cent from its 52-week low of Rs 50.42 per share. Read more
Pharma stock under Rs 70 jumps 11.5%; Unico Global Opportunities Fund bought 45,77,717 shares & Ebisu Global Opportunities Fund bought 45,21,028 shares Pharma stock under Rs 70 jumps 11.5%; Unico Global Opportunities Fund bought 45,77,717 shares & Ebisu Global Opportunities Fund bought 45,21,028 shares The company has a market cap of over Rs 300 crore and the stock is up by 24.1 per cent from its 52-week low of Rs 50.42 per share. DSIJ Intelligence / Wednesday, March 5, 2025 0 230 Article rating: 5.0 The company has a market cap of over Rs 300 crore and the stock is up by 24.1 per cent from its 52-week low of Rs 50.42 per share. Read more
Pharma penny stock under Rs 35 in green after acquiring 10,000 shares of its Singapore subsidiary Pharma penny stock under Rs 35 in green after acquiring 10,000 shares of its Singapore subsidiary The stock gave multibagger returns of 467 per cent from its 52-week low of Rs 5.82 per share. DSIJ Intelligence / Thursday, February 27, 2025 0 208 Article rating: 4.0 The stock gave multibagger returns of 467 per cent from its 52-week low of Rs 5.82 per share. Read more
Pharma penny stock under Rs 60 in green after bagging new order worth USD 23,000 from FIRSTVET Veterinary Medicines Trading LLC Pharma penny stock under Rs 60 in green after bagging new order worth USD 23,000 from FIRSTVET Veterinary Medicines Trading LLC The stock is up 40.14 per cent from its 52-week low of Rs 41.10 per share. DSIJ Intelligence / Thursday, December 26, 2024 0 338 Article rating: 3.9 The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent. Read more
Pharma Penny Stock Under Rs 60 In Green After Bagging A Significant New Order Worth Rs 6,28,15,000 Pharma Penny Stock Under Rs 60 In Green After Bagging A Significant New Order Worth Rs 6,28,15,000 The company has a market cap of Rs 63 crore and on Tuesday, the stock was trading at Rs 53.80 per share on NSE. DSIJ Intelligence / Tuesday, November 19, 2024 0 328 Article rating: 4.0 The company has a market cap of Rs 63 crore and on Tuesday, the stock was trading at Rs 53.80 per share on NSE. Read more
Pharma penny stock under Rs 55 in green as company bags new order worth USD 19,200 from Genet International & FIRSTVET Veterinary Medicines Trading LLC Pharma penny stock under Rs 55 in green as company bags new order worth USD 19,200 from Genet International & FIRSTVET Veterinary Medicines Trading LLC The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent. DSIJ Intelligence / Wednesday, October 30, 2024 1 1083 Article rating: 3.5 The stock is up 34.21 per cent from its 52-week low of Rs 38.01 per share. Read more
Penny stock below Rs 50 jumps over 10 per cent as pharma company bags new order worth USD 17,700 from Al-Saqr Agro For Agricultural And Veterinary Entries Penny stock below Rs 50 jumps over 10 per cent as pharma company bags new order worth USD 17,700 from Al-Saqr Agro For Agricultural And Veterinary Entries The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent. DSIJ Intelligence / Thursday, September 19, 2024 0 574 Article rating: 3.9 The stock is up 30 per cent from its 52-week low of Rs 37.50 per share. Read more
230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it? 230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it? The company has delivered returns of 14.5 per cent over the past 3 years and returns of 230 per cent over the past 5 years. DSIJ Intelligence / Friday, July 14, 2023 0 14458 Article rating: 4.1 The company has a ROCE of 19.4 per cent and a ROE of 19.1 per cent. Read more
This innovative Pharma company launches Thiamine Hydrochloride Injection USP in the United States! This innovative Pharma company launches Thiamine Hydrochloride Injection USP in the United States! The company holds a leadership position in cardiovascular, anti-diabetic and respiratory segments and is the third-largest pharmaceutical company in the U.S. by prescriptions. DSIJ Intelligence / Monday, June 19, 2023 0 381 Article rating: 4.0 A global pharmaceutical company, has announced the launch of Thiamine Hydrochloride Injection USP, following the approval of its alliance partner Caplin Steriles Limited's ANDA by the U.S. FDA. Read more
Biggest IPO of 2023 gets listed; stock surges 31.86 per cent from issue price Biggest IPO of 2023 gets listed; stock surges 31.86 per cent from issue price IPO listed with a 20.37 per cent premium on the BSE! DSIJ Intelligence / Tuesday, May 9, 2023 0 1548 Article rating: 4.5 IPO listed with a 20.37 per cent premium on the BSE! Read more
Upper Circuit: This micro-cap pharma stock reported stellar Q3FY23 results! Upper Circuit: This micro-cap pharma stock reported stellar Q3FY23 results! In an aim to expand their product portfolio, the company is focusing on developing multiple manufacturing sites DSIJ Intelligence / Monday, January 30, 2023 0 468 Article rating: 3.7 They initiated contract manufacturing from three new locations this quarter and with this, they are currently manufacturing at nine locations across India Read more
Only buyers: Shares of this pharmaceutical company are locked at 20 per cent upper circuit. Do you own it? Only buyers: Shares of this pharmaceutical company are locked at 20 per cent upper circuit. Do you own it? This stock is currently available at a PE multiple of 21.47 and an ROE of 9.68, all of which indicate good management effectiveness. DSIJ Intelligence / Tuesday, November 15, 2022 0 3193 Article rating: 4.3 This stock is currently available at a PE multiple of 21.47 and an ROE of 9.68, all of which indicate good management effectiveness. Read more
Shilpa Medicare skyrockets by 10.47 per cent on a weak market day! Shilpa Medicare skyrockets by 10.47 per cent on a weak market day! The board of the company also has recommended a dividend of Rs 1.10 per equity share for the financial year ended March 31, 2022.  DSIJ Intelligence / Tuesday, May 24, 2022 0 537 Article rating: 5.0 The shares of Shilpa Medicare soared 10.47 per cent to Rs 453.25 on BSE after the company announced promising results for the quarter that ended on March 31, 2022. Read more